Study to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer

Clinical trial NCT06555263 · WITHDRAWN

Trial details

NCT number: NCT06555263
Sponsor: Sutro Biopharma, Inc.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer Lung Cancer Metastatic Lung Cancer, Nonsmall Cell Lung Cancer Non-Small Cell Stage IIIB Lung Cancer Non-small Cell Stage IV Lung Cancer, Non-small Cell

Start date: 2024-08-21
Primary completion: 2025-05-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.